September 21, 2010 (Chinavestor) Chinese medical device maker China Medical Technologies (Nasdaq:CMED) is planning to meet with investors this week regarding the company's planned sale of $200 million in five- or seven-year bonds. Deutsche Bank (NYSE: DB) and Standard Chartered are helping arrange the investor meetings, according to Bloomberg News.
The bond sale will be China Medical's (Nasdaq:CMED) first since a $276 million debt sale in 2008. China Medial (Nasdaq:CMED) plans to sell the notes to buy back convertible bonds due in 2011 and 2013, according to Fitch Ratings. The ratings agency plans to rate the new issue "B+," the fourth-highest junk rating.
The company has planned investor meetings in Hong Kong tomorrow, in Singapore on Sept. 23, in London on Sept. 24 and in the U.S. next week, Bloomberg reported.